NCT03646396招募中不适用
Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection
Sherief Abd-Elsalam1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年8月1日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Number of patients with change in VEGF, TGFB1
研究概览
简要总结
The study aimed at study of the Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection
详细描述
The study primary aim was at evaluation of the Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Chronic HCV patients
排除标准
- •HIV or HBV.
- •Malignancy.
- •Pregnancy.
研究组 & 干预措施
Sofosbuvir-daclatasvir
Experimental
Sofosbuvir-daclatasvir for 3 months
干预措施: Sofosbuvir-daclatasvir (Drug)
结局指标
主要结局
Number of patients with change in VEGF, TGFB1
时间窗: 6 months
Number of patients with change in VEGF, TGFB1
次要结局
未报告次要终点
研究者
Sherief Abd-Elsalam
PhDTropical Medicine
Tanta University
研究点 (1)
Loading locations...
相似试验
已完成
3 期
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.Hepatitis CNCT02032888Bristol-Myers Squibb238
已完成
2 期
Comparison of the effect of Sofosbuvir + Daclatasvir (Sovodac) and Ribavirin in Covid-19COVID-19.2019-nCOV diseaseU07.1IRCT20200324046850N2Abadan University of Medical Sciences62
撤回
2 期
A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)Hepatitis CNCT02556086Bristol-Myers Squibb
已完成
2 期
Sofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4Chronic Hepatitis C Virus InfectionNCT04387526Beni-Suef University946
已完成
2 期
Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial DysfunctionType 2 Diabetes Mellitus Related Endothelial DysfunctionNCT00696722Radboud University Medical Center16